InSights Hub

Showing 241 to 250 of 364 (Page 25)

Guidelines+ Trials Spotlight - Produce

Food is Medicine & Produce Prescriptions – Guidelines+ Trials Spotlight

Nutrition plays a crucial role in maintaining overall health and well-being. A study from The Lancet revealed that poor diet is responsible for one in five deaths globally, contributing to a variety of chronic diseases such as cardiovascular diseases, cancer, and type 2 diabetes. Unfortunately, individuals with lower incomes, those residing in rural areas, and […]

Read More
Guidelines+ Trials Rundown - Celiac Disease

Celiac Disease in Adults – Guidelines+ Trials Rundown

Today we’re going to look at the ongoing studies and clinical trials specific to celiac disease in adults. The following list has been curated by evaluating the current Phase 2 and 3 clinical trials for celiac disease in adults conducted in the United States. Please note that the dates provided are approximate and may be […]

Read More
Guidelines + Trials Migraine Prevention

Migraine Prevention in Adults – Guidelines+ Trials Rundown

Today we’re going to cover the second article in a two part series that takes a look at the ongoing studies and clinical trials specific to management of migraine in adults, including acute migraine treatment and migraine prevention (both chronic migraine prevention and episodic migraine prevention).  The focus of Part 1 was Acute Migraine Treatment […]

Read More
ENDO 2024 Recap

Endocrine Society’s Annual Meeting Recap -Diabetes Research at ENDO 24

The Endocrine Society’s annual meeting, ENDO 2024, was held from June 1-4 in Boston, MA. This event served as a leading gathering for professionals in the field of endocrinology. The conference showcased esteemed experts and influential thought leaders who provided insightful presentations on cutting-edge research, treatments, and developments in endocrine disorders. Highlighted below are some […]

Read More
ASCO Conference Recap

2024 ASCO Annual Meeting Recap – The Latest Research on Lung Cancer

The Annual Meeting of the American Society of Clinical Oncology (ASCO) was held from May 31 to June 4, 2024, in Chicago, IL. This event serves as a pivotal gathering for healthcare professionals committed to enhancing patient care and outcomes within the field of oncology. A prominent topic of discussion at ASCO24 was lung cancer. […]

Read More
Guidelines+ Journals Rundown Neurology

Top Neurology Articles June 2024 – Guidelines+ Journals

In this post, we will be taking a closer look at some of the most popular neurology-related articles recently published across medical journals. Burden of Stroke Attributable to Nonoptimal Temperature in 204 Countries and Territories Effect of Intermittent Oro-Esophageal Tube Feeding in Bulbar Palsy After Ischemic Stroke: A Randomized Controlled Study Downstream Biomarker Effects of […]

Read More
SVS: VAM 2024 Conference Preview

Vascular Annual Meeting (VAM24) – Conference Preview on Aortic Disease

The 2024 Vascular Annual Meeting (VAM24) will be held from June 19-22 in Chicago, Illinois. It is the Society of Vascular Surgery’s (SVS) premier meeting, offering a wealth of valuable scientific content tailored for every member of the vascular care team. If you have not already done so, we recommend registering here for this year’s […]

Read More
FDA Approvals - May 2024

Guideline Med Alerts & FDA Approvals – May 2024

Breyanzi (Bristol Myers Squibb)Expanded Indication Retevmo (Eli Lilly) Expanded Indication Onyda XR (Tris Pharma)  Bkemv (Amgen)Biosimilar to Soliris Opuviz (Biogen) Biosimilar to Eylea Yesafili (Biocon Biologics) Biosimilar to Eylea Imdelltra (Amgen)  Clinolipid (Baxter) Expanded Indication ColoSense (Geneoscopy) New Formulation Myhibbin (Azurity Pharmaceuticals) New Formulation Cyltezo (Boehringer Ingelheim) New Formulation Sign up for alerts and stay informed on […]

Read More
Upcoming FDA Approvals & Decisions - June 2024

Upcoming FDA Decisions – June 2024

The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]

Read More